👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Jason Lester
Oncology
English
13,230+
Patients seen
5
Years in practice
9
Publications
1
Languages spoken
About
Dr Jason Lester is an oncologist based at GenesisCare in Bristol. He specialises in the management of lung cancer, mesothelioma, prostate, kidney, and bladder cancer.
He is able to offer the following treatments:
• Chemotherapy
• External beam radiotherapy
• Genetic genomic testing
• image-guided radiotherapy
• immunotherapy
• intensity-modulated radiotherapy
• palliative radiotherapy
• Stereotactic ablative radiotherapy
• Surface-guided radiotherapy
• volumetric modulated arc therapy
Dr Lester gained his medical degree in 1993 from the University of London and went on to train in general medicine in the south of England. In 2003, he completed his oncology training in Wales and became a consultant oncologist.
He has expertise in a wide range of radiotherapy treatments, such as brachytherapy, proton beam therapy, and conventional conformal radiotherapy. He is also experienced in chemotherapy, hormone therapy, immunotherapy, and targeted treatment.
There is such a wide range of potential therapies for cancer that it is necessary to understand which approach is best for an individual. Dr Lester, therefore, uses cancer genomic analysis to create a personalised treatment plan for his patients. He aims to deliver evidence-based treatment and ensures that his patients understand their treatment fully.
Dr Lester is a member of the Royal College of Physicians and a fellow of the Royal College of Radiologists.
He is able to offer the following treatments:
• Chemotherapy
• External beam radiotherapy
• Genetic genomic testing
• image-guided radiotherapy
• immunotherapy
• intensity-modulated radiotherapy
• palliative radiotherapy
• Stereotactic ablative radiotherapy
• Surface-guided radiotherapy
• volumetric modulated arc therapy
Dr Lester gained his medical degree in 1993 from the University of London and went on to train in general medicine in the south of England. In 2003, he completed his oncology training in Wales and became a consultant oncologist.
He has expertise in a wide range of radiotherapy treatments, such as brachytherapy, proton beam therapy, and conventional conformal radiotherapy. He is also experienced in chemotherapy, hormone therapy, immunotherapy, and targeted treatment.
There is such a wide range of potential therapies for cancer that it is necessary to understand which approach is best for an individual. Dr Lester, therefore, uses cancer genomic analysis to create a personalised treatment plan for his patients. He aims to deliver evidence-based treatment and ensures that his patients understand their treatment fully.
Dr Lester is a member of the Royal College of Physicians and a fellow of the Royal College of Radiologists.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Jason Lester
Education & training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Oncology
Career & appointments
-
2021-09–2022-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
Allianz Professional · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,683 |
| Annual physical exam | 99395 | 2,253 |
| Vaccination administration | 90471 | 1,837 |
| Minor procedure (skin) | 17110 | 1,458 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 10 · i10: 5
-
Long-term follow-up of Oncology across GB
DOI: 10.2854/euroclin.2026.0 · PMID: 31604873 · cited by 3
-
Validation of clinical scoring in Oncology
DOI: 10.9372/euroclin.2025.1 · PMID: 36132973 · cited by 121
-
Long-term follow-up of Oncology across GB
DOI: 10.2642/euroclin.2024.2 · PMID: 39172623 · cited by 111
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2022
- national college of family doctors — Member · since 2022
- European Union of Medical Specialists (UEMS) — Member · since 2022
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · jason.lester@euroclinics.example
